[{"Assets_0_FY_USD":1530704000.0,"EarningsPerShareBasic_1_FY_USD":0.59,"EarningsPerShareBasic_4_FY_USD":2.47,"EarningsPerShareDiluted_1_FY_USD":0.58,"EarningsPerShareDiluted_4_FY_USD":2.44,"NetIncomeLoss_1_FY_USD":52369000.0,"NetIncomeLoss_4_FY_USD":222045000.0,"StockholdersEquity_0_FY_USD":-108352000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":90884000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":89732000.0,"Ticker":"IDXX","CIK":"874716","name":"IDEXX LABORATORIES INC \/DE","OfficialName":"IDEXX Laboratories Inc. Common Stock","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"42180715521.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"SP500","filed":"20170217"}]